Charting a path toward overcoming glioblastoma resistance to chemotherapy
Thursday, 19 December 2024 ()
Mutational signatures etched into the cells' genome by an anti-cancer drug called temozolomide (TMZ) uncover an Achilles' heel for TMZ chemotherapy resistance, according to new research.
|
||||
You Might Like |
||||
